{"name":"Medigen Vaccine Biologics Corp.","slug":"medigen-vaccine-biologics-corp","ticker":"","exchange":"","domain":"medigenvac.com","description":"","hq":"Hsinchu Science Park","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":7,"colorKey":"oncology","drugs":[{"name":"GC FLU Quadrivalent","genericName":"GC FLU Quadrivalent","slug":"gc-flu-quadrivalent","indication":"Seasonal influenza prevention in adults and children","status":"phase_3"},{"name":"AT-501 High Dose vaccine","genericName":"AT-501 High Dose vaccine","slug":"at-501-high-dose-vaccine","indication":"Other","status":"phase_1"},{"name":"AT-501 High Dose vaccine with Adjuvant","genericName":"AT-501 High Dose vaccine with Adjuvant","slug":"at-501-high-dose-vaccine-with-adjuvant","indication":"Other","status":"phase_1"},{"name":"AT-501 Low Dose vaccine","genericName":"AT-501 Low Dose vaccine","slug":"at-501-low-dose-vaccine","indication":"Other","status":"phase_1"},{"name":"AT-501 Low Dose vaccine with Adjuvant","genericName":"AT-501 Low Dose vaccine with Adjuvant","slug":"at-501-low-dose-vaccine-with-adjuvant","indication":"Other","status":"phase_1"},{"name":"Full dose of MVC-COV1901","genericName":"Full dose of MVC-COV1901","slug":"full-dose-of-mvc-cov1901","indication":"Other","status":"phase_2"},{"name":"Half dose of MVC-COV1901","genericName":"Half dose of MVC-COV1901","slug":"half-dose-of-mvc-cov1901","indication":"Other","status":"phase_2"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"immunology","drugs":[{"name":"EV71vac","genericName":"EV71vac","slug":"ev71vac","indication":"Prevention of Enterovirus 71 (EV71) infection and hand, foot, and mouth disease (HFMD) in pediatric populations","status":"phase_3"},{"name":"Envacgen®","genericName":"Envacgen®","slug":"envacgen","indication":"COVID-19 prevention (protein subunit vaccine candidate)","status":"phase_3"},{"name":"MVC-COV1901","genericName":"MVC-COV1901","slug":"mvc-cov1901","indication":"COVID-19 prevention in adults","status":"phase_3"}]}],"pipeline":[{"name":"GC FLU Quadrivalent","genericName":"GC FLU Quadrivalent","slug":"gc-flu-quadrivalent","phase":"phase_3","mechanism":"GC FLU Quadrivalent is an inactivated influenza vaccine that stimulates the immune system to produce antibodies against four strains of influenza virus.","indications":["Seasonal influenza prevention in adults and children"],"catalyst":""},{"name":"AT-501 High Dose vaccine","genericName":"AT-501 High Dose vaccine","slug":"at-501-high-dose-vaccine","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"AT-501 High Dose vaccine with Adjuvant","genericName":"AT-501 High Dose vaccine with Adjuvant","slug":"at-501-high-dose-vaccine-with-adjuvant","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"AT-501 Low Dose vaccine","genericName":"AT-501 Low Dose vaccine","slug":"at-501-low-dose-vaccine","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"AT-501 Low Dose vaccine with Adjuvant","genericName":"AT-501 Low Dose vaccine with Adjuvant","slug":"at-501-low-dose-vaccine-with-adjuvant","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"EV71vac","genericName":"EV71vac","slug":"ev71vac","phase":"phase_3","mechanism":"EV71vac is an inactivated vaccine that stimulates the immune system to produce antibodies and cellular immunity against Enterovirus 71 (EV71).","indications":["Prevention of Enterovirus 71 (EV71) infection and hand, foot, and mouth disease (HFMD) in pediatric populations"],"catalyst":""},{"name":"Envacgen®","genericName":"Envacgen®","slug":"envacgen","phase":"phase_3","mechanism":"Envacgen is a recombinant protein subunit vaccine designed to stimulate immune responses against specific disease targets through antigen presentation.","indications":["COVID-19 prevention (protein subunit vaccine candidate)"],"catalyst":""},{"name":"Full dose of MVC-COV1901","genericName":"Full dose of MVC-COV1901","slug":"full-dose-of-mvc-cov1901","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Half dose of MVC-COV1901","genericName":"Half dose of MVC-COV1901","slug":"half-dose-of-mvc-cov1901","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"MVC-COV1901","genericName":"MVC-COV1901","slug":"mvc-cov1901","phase":"phase_3","mechanism":"MVC-COV1901 is a protein subunit vaccine that stimulates immune responses against SARS-CoV-2 by presenting viral spike protein antigens to the immune system.","indications":["COVID-19 prevention in adults"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-03-19","type":"pipeline","source":"nst.com.my","summary":"Envacgen becomes Vietnam's first EV-A71 vaccine, paving way for Southeast Asia expansion - nst.com.my","headline":"Envacgen becomes Vietnam's first EV-A71 vaccine, paving way for Southeast Asia expansion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE82eWdKc1lNQUhvZnF2U20wVnhCLXlVc01faFpjTmlGc3NCT1ExbEc0d0ZqVWV2N0VrWDItRDF2SFNZRnJOQW9INUw0Q2pKSUI1Njhnb0NybmJXZmlScTh5MncyamhDRlVWOE13cG9zVTdRdlRJUm5MaEFR?oc=5","date":"2025-02-11","type":"deal","source":"Taipei Times","summary":"Taiwan to buy 7m trivalent flu vaccines - Taipei Times","headline":"Taiwan to buy 7m trivalent flu vaccines","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxPM3hIS2NCNzNTellKVG5qRk5KMmFDYmRYZjdZRkRGalFYaGxHOTVjSEQyNTRvZjN2UlNyclRCclRYdmdsWEdSRjFmVVlWMlJCcXR1am9HbnNsOEYyc2xCMDloZFBhb20tWkRFdmJURzZjT0U2MWZ3dUg1eXNYOHNqZFpWNF9IS3lqNTJkb2hSU2VzY2ZZTndtalpCZ2piTUVXOEx5MEUwaDFidF9oTFZjSmpSUjMxSkhG?oc=5","date":"2025-01-22","type":"pipeline","source":"NAVLIN DAILY","summary":"Envacgen Enterovirus A71Vaccine to Launch in Vietnam, Expanding Across ASEAN - NAVLIN DAILY","headline":"Envacgen Enterovirus A71Vaccine to Launch in Vietnam, Expanding Across ASEAN","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxNbF9QRzZpSGVTSGd4OXcwSEhrUVZpM0Nib0prcm5rbDRtS1BscXpOMVBydUhjdmZVMUJndmJBdGZOSkdsQ08zZExNcnlBU2swbmYzOTYwTUkwUE1jc3NTMTliY3RFa0o5QXROZFNCZnNzVEUtWGgyN1BCOHFsNFY0TFhVV2Fkb0JjOWxkc0UzMFBVamx3ZEdBSUJ4aFZsMWpKSUlZNXRhTDdTbXhxVDkzaQ?oc=5","date":"2023-08-31","type":"pipeline","source":"healthpolicy-watch.news","summary":"WHO Secures First COVID-19 Vaccine Licence From Private Pharmaceutical Company - healthpolicy-watch.news","headline":"WHO Secures First COVID-19 Vaccine Licence From Private Pharmaceutical Company - healthpolicy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFAybl9pd2xnRzktUjcxYmpubDVqT2Q4eEc3NHZmZF9hRUtrclpteHNLeWtCUDFnNU5TZE1pUUNJTkExZHBuTFROOEVtb1BZVzRHN09zcGFzSzlSajhWbTVQMnVvVUFIeTBfNkQ0Qlpn0gFyQVVfeXFMTTZqdWNVaVo5QVQ1OTlHRWVlTzUtWWRKdmQ3TzhDZG5DVDAwbi1hcEgzOUFJcW5NTDdCT1hxNUZjT0FlRmlLRS1MSWt4VjcwVDNoZnlmSkx3U1ppU0xreDh6X1lKZ0ZZbS1tbjlMNEs5UXJR?oc=5","date":"2023-03-13","type":"deal","source":"koreabiomed.com","summary":"Flu vaccine GC Biopharma licensed out to MVC scores nod in Taiwan - koreabiomed.com","headline":"Flu vaccine GC Biopharma licensed out to MVC scores nod in Taiwan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTFBDOVNCcWxPMnpFZEpoQlpKOWZnbUdOcVhsT01RZC03aG9VdDlNZWZucWVYTWJha09IME9jVl9KcHkwckF1VHM3NVpUdm5rRTdkaHRsYS12RGI2LWpYM1U5bk95R1RWRDBJYzQwMnIzQVBCWHlzYkdKOUxn?oc=5","date":"2022-10-28","type":"deal","source":"Taipei Times","summary":"Minister denies Choice merger predated contract - Taipei Times","headline":"Minister denies Choice merger predated contract","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxNMmhYNGpWQVJUVnJxYlEyWnZ1SnQ0am9LLW9DcEpCWmRwdlB6aXZDc0pyWDA2ZUJBeWFBM0ZGOHNROVpJeF9MQmxpTnZkS2t3SlZybGNkZzhDTzZDRlhBQzZiYzlpckY5OWxWUFVaU1lueDNYOVpiT0RDaE5PdHc1VlZnenRDWkdsUUpndmNHQVcySERYOS1Sd1F3MTd2dnV0T1hBQWxXMEk0SEt5a2FnYmRmaHdxZw?oc=5","date":"2022-01-15","type":"trial","source":"BioPharma APAC","summary":"Medigen's MVC-COV1901 Selected for WHO COVID-19 Solidarity Trial Vaccines - BioPharma APAC","headline":"Medigen's MVC-COV1901 Selected for WHO COVID-19 Solidarity Trial Vaccines","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTFAwMnRZbnZZMkk0YWdvRllHeUdVWkVRTmJiRWhhVW94STBXckltVTJXTnpCRHpISTR1WmxTd3QxTTJsc09MZm5sZW90NkJfeW5JS1R2RnV5c3RFczNJUnRjNThNN2hFTXM?oc=5","date":"2021-08-19","type":"pipeline","source":"天下雜誌","summary":"How did Medigen make Taiwan’s first homegrown COVID-19 vaccine?｜Industry｜2021-08-19｜web only - 天下雜誌","headline":"How did Medigen make Taiwan’s first homegrown COVID-19 vaccine?｜Industry｜2021-08-19｜web only - 天下雜誌","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE9zOWN5TEYzRVFfNnBsaEFkc3dhdnJwdU1RVm1HLVpnUDlvZ3VfQUJCNXlQMkhSMlZHVnFCUncydEZsbk9zNTlONDRHcmktUm80WHAwYmRTVEU2QW1WSGxwVVkzVjhTbUJkdVNDZGhPRWYtZmFVZEE?oc=5","date":"2021-07-08","type":"trial","source":"Taipei Times","summary":"Medigen seeks trials in Paraguay - Taipei Times","headline":"Medigen seeks trials in Paraguay","sentiment":"neutral"}],"patents":[],"drugCount":10,"phaseCounts":{"phase_3":4,"phase_1":4,"phase_2":2},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}